Bruker Introduces A Broad Range of New Life Science and Analytical High-Performance Systems and Innovative Solutions at Pittcon 2008
NEW ORLEANS, Mar 03, 2008 (BUSINESS WIRE) -- Bruker Corporation (NASDAQ: BRKR) today introduces numerous innovative high-performance systems and breakthrough solutions for life science and materials research, for molecular imaging research, for homeland security and environmental monitoring, as well as for applied and industrial analysis at Pittcon 2008.
Several new Bruker solutions are available for cutting-edge small molecule analysis in the (...)
Bruker Corporation Reports Record Revenues and Earnings for the Fourth Quarter and Full Year 2007
Full Year 2007 Revenue Increased 19% (after Currency Adjustments) to $547.6 Million, and Full Year 2007 Net Income Grew 70% to $31.5 MillionBILLERICA, Mass., Feb 28, 2008 (BUSINESS WIRE) -- Bruker Corporation (NASDAQ: BRKR) today reported financial results for the fourth quarter and full year ended December 31, 2007. The financial information included herein does not include the results of the Bruker BioSpin Group, which was acquired on February (...)
Bruker Previews Selected Pittcon 2008 Product Introductions
Bruker will again host Annual Investor Booth Tour and Annual Press Luncheon for Editors of Scientific and Trade Journals at Pittcon 2008
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation today announced its annual new product booth tour for institutional investors and financial analysts at Pittcon 2008 in New Orleans. The investor tour will start promptly on Tuesday, March 4 th at 10 a.m. Central Time at the Company ' s booth #4041, and will (...)
Bruker BioSciences Non-Affiliated Shareholders Overwhelmingly Approve Acquisition of Bruker BioSpin Group
BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 25, 2008--After the Company's Special Stockholders Meeting held this morning in Boston, Bruker BioSciences Corporation (NASDAQ: BRKR) announces that its stockholders have approved the acquisition of the companies comprising the Bruker BioSpin Group.
At today's Special Meeting all proposals were approved with overwhelming majorities by the Bruker BioSciences stockholders. In particular, the three proposals (...)
Bruker BioSciences Corporation to Release Fourth Quarter and Full Year 2007 Financial Results on February 28, 2008
BILLERICA, Mass., Feb 21, 2008 (BUSINESS WIRE) -- Bruker BioSciences Corporation (NASDAQ:BRKR) announced today that it plans to release its fourth quarter and full year 2007 financial results on Thursday, February 28, 2008 before the market opens. Bruker BioSciences will then host an operator-assisted earnings conference call that morning at 9 a.m. Eastern Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live (...)
Bruker BioSciences Announces Filing of Definitive Proxy and Expiration of HSR Waiting Period for Planned Acquisition of Bruker BioSpin Group
Special Meeting of BRKR Stockholders to Be Held on February 25, 2008
BILLERICA, Mass.--(BUSINESS WIRE)--Jan. 17, 2008--Bruker BioSciences Corporation (NASDAQ: BRKR) today announced that it has filed with the Securities and Exchange Commission its definitive proxy statement regarding the previously announced, planned acquisition of the Bruker BioSpin group of companies. A special meeting of Bruker BioSciences stockholders to consider and vote upon (...)
Bruker BioSciences to Present at 26th Annual JPMorgan Healthcare Conference
Live Webcast on January 10th at 11:00 AM Pacific Time from San FranciscoBILLERICA, Mass., Jan 07, 2008 (BUSINESS WIRE) -- Bruker BioSciences Corporation today announced that it will join other leading healthcare and life sciences companies in presenting at the 26th Annual JPMorgan Healthcare Conference. Frank Laukien, CEO, and Bill Knight, CFO, will present an update on the Company.
The presentation will be webcast live starting at 11:00 AM (...)
Proxeon and Bruker Daltonik Announce OEM Agreement
Bruker Daltonik to Offer Proxeon’s EASY-nLC, a Nanoscale Chromatography System, as Part of their LC/MS Product Portfolio Odense, Denmark and Bremen, Germany- November 15th, 2007- Proxeon A/S and Bruker Daltonik GmbH today announced that the companies have entered into an OEM agreement. Under the agreement, Bruker Daltonik will sell Proxeon’s nanoscale chromatography system, EASY-nLC™, together with their well-established range of products for mass (...)
Bruker BioSciences Reports Financial Results for the Third Quarter of 2007
BILLERICA, Mass., Oct 29, 2007 (BUSINESS WIRE) -- Bruker BioSciences Corporation (NASDAQ: BRKR) today reported its financial results for the three and nine months ended September 30, 2007. For the third quarter of 2007, revenue increased by 25% to $131.6 million, compared to revenue of $104.9 million in the third quarter of 2006. Excluding the effects of foreign currency translation, third quarter 2007 revenue increased by 20% year-over-year. Net income (...)
Bruker BioSciences Corporation to Release Third Quarter 2007 Financial Results on October 29, 2007
BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 25, 2007--Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its third quarter 2007 financial results on Monday, October 29, 2007 before the market opens. Bruker BioSciences will then host an operator-assisted earnings conference call that morning at 10 a.m. Eastern Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live web broadcast symbol. The webcast will (...)
